Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ilenia Migliaccio
An RB-1 Loss of Function Gene Signature as a Tool to Predict Response to Neoadjuvant Chemotherapy Plus Anti-Her2 Agents: A Substudy of the NeoALTTO Trial (BIG 1-06)
Therapeutic Advances in Medical Oncology
Oncology
The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy
Cancers
Cancer Research
Oncology
Related publications
Anti-Her2 CD4+ T-Helper Type 1 Response Is a Novel Immune Correlate to Pathologic Response Following Neoadjuvant Therapy in HER2-positive Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Molecular Biomarkers to Predict Response to Neoadjuvant Chemotherapy for Bladder Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
Frontiers in Oncology
Cancer Research
Oncology
RB-Pathway Disruption Is Associated With Improved Response to Neoadjuvant Chemotherapy in Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-Her2 Agents in a Large Asian Cancer Patient Cohort
Frontiers in Oncology
Cancer Research
Oncology
Deletions of Multidrug Resistance Gene Loci in Breast Cancer Leads to the Down-Regulation of Its Expression and Predict Tumor Response to Neoadjuvant Chemotherapy
Oncotarget
Oncology
A Phase I Study of Neoadjuvant Chemotherapy With Gemcitabine Plus Oral S-1 for Resectable Pancreatic Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Validation of the 21-Gene Test as a Predictor of Clinical Response to Neoadjuvant Hormonal Therapy for ER+, HER2-negative Breast Cancer: The TransNEOS Study
Breast Cancer Research and Treatment
Cancer Research
Oncology
A Case of Gastric Medullary Carcinoma Showing a Complete Histological Response After S-1/CDDP Neoadjuvant Chemotherapy
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
